Clinical Applications of PET in Oncology
Indexed incrossrefpubmed
Abstract
Positron emission tomography (PET) provides metabolic information that has been documented to be useful in patient care. The properties of positron decay permit accurate imaging of the distribution of positron-emitting radiopharmaceuticals. The wide array of positron-emitting radiopharmaceuticals has been used to characterize multiple physiologic and pathologic states. PET is used for characterizing brain disorders such as Alzheimer disease and epilepsy and cardiac disorders such as coronary artery disease and myocardial viability. The neurologic and cardiac applications of PET are not covered in this review. The major utilization of PET clinically is in oncology and consists of imaging the distribution of…
Citation impact
854
total citations
- FWCI
- 48.59
- Percentile
- 100%
- References
- 199
Citations per year
Authors
3Topics & keywords
Topics
Keywords
- Medicine
- Positron emission tomography
- Fluorodeoxyglucose
- Pet imaging
- Coronary artery disease
- Cardiac imaging
- Clinical Oncology
- Positron
No related works found for this paper.